Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 3/2019

Open Access 01-03-2019 | Original Article

Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan

Authors: Shunsuke Endo, Norihiko Ikeda, Takashi Kondo, Jun Nakajima, Haruhiko Kondo, Yoshihisa Shimada, Masami Sato, Shinichi Toyooka, Yoshinori Okada, Yukio Sato, Ichiro Yoshino, Morihito Okada, Meinoshin Okumura, Masayuki Chida, Eriko Fukuchi, Hiroaki Miyata

Published in: General Thoracic and Cardiovascular Surgery | Issue 3/2019

Login to get access

Abstract

Background

Broncho-pleural fistula (BPF) and respiratory failure (RF) are life-threatening complications after lung cancer surgery and can result in long-term hospitalization and decreased quality of life. Risk assessments for BPF and RF in addition to mortality and major morbidities are indispensable in surgical decision-making and perioperative care.

Methods

The characteristics and operative data of 80,095 patients who had undergone lung cancer surgery were derived from the 2014 and 2015 National Clinical Database (NCD) of Japan datasets. After excluding 1501 patients, risk models were developed from these data and validated by another dataset for 42,352 patients derived from the 2016 NCD dataset. Receiver operating characteristic curves were generated for postoperative BPF and RF development. The concordance-index was used to assess the discriminatory ability and validity of the model.

Results

BPF and RF occurred in 259 (0.3%) and 420 patients (0.5%), respectively, in the model development dataset and in 129 (0.3%) and 198 patients (0.5%), respectively, in the model validation dataset. Characteristic variables including types of surgery and comorbidities were identified as risk factors for BPF and RF, respectively. The concordance indexes of assessments for BPF and RF were 0.847 (p < 0.001) and 0.848 (p < 0.001), respectively, for the development dataset and 0.850 (p < 0.001) and 0.844 (p < 0.001), respectively, for the validation dataset.

Conclusions

These models are satisfactory for predicting BPF and RF after lung cancer surgery in Japan and could guide preoperative assessment and optimal measures for preventing BPF and RF.
Appendix
Available only for authorised users
Literature
1.
go back to reference Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Yokoi K, et al. Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014–2015. Eur J Cardiothorac Surg. 2017;52:1182–9.CrossRefPubMedPubMedCentral Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Yokoi K, et al. Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014–2015. Eur J Cardiothorac Surg. 2017;52:1182–9.CrossRefPubMedPubMedCentral
2.
go back to reference Fernandez FG, Kosinski AS, Burfeind W, Park B, DeCamp MM, Seder C, et al. The Society of Thoracic Surgeons lung cancer resection risk model: higher quality data and superior outcomes. Ann Thorac Surg. 2016;102:370–7.CrossRefPubMedPubMedCentral Fernandez FG, Kosinski AS, Burfeind W, Park B, DeCamp MM, Seder C, et al. The Society of Thoracic Surgeons lung cancer resection risk model: higher quality data and superior outcomes. Ann Thorac Surg. 2016;102:370–7.CrossRefPubMedPubMedCentral
3.
go back to reference Brunelli A, Salati M, Rocco G, Varela G, Van Raemdonck D, Decaluwe H, et al. ESTS Database Committee. European risk models for morbidity (EuroLung1) and mortality (EuroLung2) to predict outcome following anatomic lung resections: an analysis from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg. 2016;51:490–7. Brunelli A, Salati M, Rocco G, Varela G, Van Raemdonck D, Decaluwe H, et al. ESTS Database Committee. European risk models for morbidity (EuroLung1) and mortality (EuroLung2) to predict outcome following anatomic lung resections: an analysis from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg. 2016;51:490–7.
4.
go back to reference Pforr A, Pagès PB, Baste JM, Thomas P, Falcoz PE, Lepimpec Barthes F, et al. Epithor Project French Society of Thoracic and Cardiovascular Surgery. A predictive score for bronchopleural fistula established using the French Database Epithor. Ann Thorac Surg. 2016;101:287–93.CrossRefPubMed Pforr A, Pagès PB, Baste JM, Thomas P, Falcoz PE, Lepimpec Barthes F, et al. Epithor Project French Society of Thoracic and Cardiovascular Surgery. A predictive score for bronchopleural fistula established using the French Database Epithor. Ann Thorac Surg. 2016;101:287–93.CrossRefPubMed
5.
go back to reference Okuda M, Go T, Yokomise H. Risk factor of bronchopleural fistula after general thoracic surgery: review article. Gen Thorac Cardiovasc Surg. 2017;65:679–85.CrossRefPubMed Okuda M, Go T, Yokomise H. Risk factor of bronchopleural fistula after general thoracic surgery: review article. Gen Thorac Cardiovasc Surg. 2017;65:679–85.CrossRefPubMed
6.
go back to reference Amar D, Munoz D, Shi W, Zhang H, Thaler HT. A clinical prediction rule for pulmonary complications after thoracic surgery for primary lung cancer. Anesth Analg. 2010;110:1343–8.CrossRefPubMed Amar D, Munoz D, Shi W, Zhang H, Thaler HT. A clinical prediction rule for pulmonary complications after thoracic surgery for primary lung cancer. Anesth Analg. 2010;110:1343–8.CrossRefPubMed
7.
go back to reference Miyata H, Gotoh M, Hashimoto H, Motomura N, Murakami A, Tomotaki A, et al. Challenges and prospects of a clinical database linked to the board certification system. Surg Today. 2014;44:1991–9.CrossRefPubMed Miyata H, Gotoh M, Hashimoto H, Motomura N, Murakami A, Tomotaki A, et al. Challenges and prospects of a clinical database linked to the board certification system. Surg Today. 2014;44:1991–9.CrossRefPubMed
8.
go back to reference Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Yokoi K, et al. Development of an annually updated Japanese national clinical database for chest surgery in 2014. Gen Thorac Cardiovasc Surg. 2016;64:569–76.CrossRefPubMedPubMedCentral Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Yokoi K, et al. Development of an annually updated Japanese national clinical database for chest surgery in 2014. Gen Thorac Cardiovasc Surg. 2016;64:569–76.CrossRefPubMedPubMedCentral
9.
go back to reference Gotoh M, Miyata H, Hashimoto H, Wakabayashi G, Konno H, Miyakawa S, et al. National Clinical Database feedback implementation for quality improvement of cancer treatment in Japan: from good to great through transparency. Surg Today. 2016;46:38–47.CrossRefPubMed Gotoh M, Miyata H, Hashimoto H, Wakabayashi G, Konno H, Miyakawa S, et al. National Clinical Database feedback implementation for quality improvement of cancer treatment in Japan: from good to great through transparency. Surg Today. 2016;46:38–47.CrossRefPubMed
10.
go back to reference Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE 2nd, Landreneau RJ, et al ACOSOG Z0030 Study Group. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81:1013–9. (discussion 1019–20).CrossRefPubMed Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE 2nd, Landreneau RJ, et al ACOSOG Z0030 Study Group. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81:1013–9. (discussion 1019–20).CrossRefPubMed
11.
go back to reference Thomas PA, Berbis J, Baste JM, Le Pimpec-Barthes F, Tronc F, Falcoz PE, et al. EPITHOR group. Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes. J Thorac Cardiovasc Surg. 2015;149:73.82.CrossRefPubMed Thomas PA, Berbis J, Baste JM, Le Pimpec-Barthes F, Tronc F, Falcoz PE, et al. EPITHOR group. Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes. J Thorac Cardiovasc Surg. 2015;149:73.82.CrossRefPubMed
12.
go back to reference Thomas PA, Berbis J, Falcoz PE, Le Pimpec-Barthes F, Bernard A, Jougon J, et al. EPITHOR group. National perioperative outcomes of pulmonary lobectomy for cancer: the influence of nutritional status. Eur J Cardiothorac Surg. 2014;45:652–9. (discussion 659).CrossRefPubMed Thomas PA, Berbis J, Falcoz PE, Le Pimpec-Barthes F, Bernard A, Jougon J, et al. EPITHOR group. National perioperative outcomes of pulmonary lobectomy for cancer: the influence of nutritional status. Eur J Cardiothorac Surg. 2014;45:652–9. (discussion 659).CrossRefPubMed
14.
go back to reference Kobayashi S, Karube Y, Nishihira M, Inoue T, Araki O, Maeda S, et al. Postoperative pyothorax a risk factor for acute exacerbation of idiopathic interstitial pneumonia following lung cancer resection. Gen Thorac Cardiovasc Surg. 2016;64:476–80.CrossRefPubMed Kobayashi S, Karube Y, Nishihira M, Inoue T, Araki O, Maeda S, et al. Postoperative pyothorax a risk factor for acute exacerbation of idiopathic interstitial pneumonia following lung cancer resection. Gen Thorac Cardiovasc Surg. 2016;64:476–80.CrossRefPubMed
15.
go back to reference Busti AJ, Hooper JS, Amaya CJ, Kazi S. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy. 2005;25:1566–91.CrossRefPubMed Busti AJ, Hooper JS, Amaya CJ, Kazi S. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy. 2005;25:1566–91.CrossRefPubMed
16.
go back to reference Li SJ, Fan J, Zhou J, Ren YT, Shen C, Che GW. Diabetes mellitus and risk of bronchopleural fistula after pulmonary resections: a meta-analysis. Ann Thorac Surg. 2016;102:328–39.CrossRefPubMed Li SJ, Fan J, Zhou J, Ren YT, Shen C, Che GW. Diabetes mellitus and risk of bronchopleural fistula after pulmonary resections: a meta-analysis. Ann Thorac Surg. 2016;102:328–39.CrossRefPubMed
17.
go back to reference Takahashi S, Go T, Kasai Y, Yokomise H, Shibata T. Relationship between dose-volume parameters and pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for lung cancer. Strahlenther Onkol. 2016;192:658–67.CrossRefPubMed Takahashi S, Go T, Kasai Y, Yokomise H, Shibata T. Relationship between dose-volume parameters and pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for lung cancer. Strahlenther Onkol. 2016;192:658–67.CrossRefPubMed
18.
go back to reference Shekar K, Foot C, Fraser J, Ziegenfuss M, Hopkins P, Windsor M. Bronchopleural fistula: an update for intensivists. J Crit Care. 2010;25:47.55.CrossRefPubMed Shekar K, Foot C, Fraser J, Ziegenfuss M, Hopkins P, Windsor M. Bronchopleural fistula: an update for intensivists. J Crit Care. 2010;25:47.55.CrossRefPubMed
19.
go back to reference Satoh Y, Okumura S, Nakagawa K, Horiike A, Ohyanagi F, Nishio M, et al. Postoperative ischemic change in bronchial stumps after primary lung cancer resection. Eur J Cardiothorac Surg. 2006;30:172–6.CrossRefPubMed Satoh Y, Okumura S, Nakagawa K, Horiike A, Ohyanagi F, Nishio M, et al. Postoperative ischemic change in bronchial stumps after primary lung cancer resection. Eur J Cardiothorac Surg. 2006;30:172–6.CrossRefPubMed
20.
go back to reference Sfyridis PG, Kapetanakis EI, Baltayiannis NE, Bolanos NV, Anagnostopoulos DS, Markogiannakis A, et al. Bronchial stump buttressing with an intercostal muscle flap in diabetic patients. Ann Thorac Surg. 2007;84:967–71.CrossRefPubMed Sfyridis PG, Kapetanakis EI, Baltayiannis NE, Bolanos NV, Anagnostopoulos DS, Markogiannakis A, et al. Bronchial stump buttressing with an intercostal muscle flap in diabetic patients. Ann Thorac Surg. 2007;84:967–71.CrossRefPubMed
21.
go back to reference Di Maio M, Perrone F, Deschamps C, Rocco G. A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy. Eur J Cardiothorac Surg. 2015;48:196–200.CrossRefPubMed Di Maio M, Perrone F, Deschamps C, Rocco G. A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy. Eur J Cardiothorac Surg. 2015;48:196–200.CrossRefPubMed
22.
go back to reference Cardillo G, Carbone L, Carleo F, Galluccio G, Di Martino M, Giunti R, et al. The rationale for treatment of postresectional bronchopleural fistula: analysis of 52 patients. Ann Thorac Surg. 2015;100:251–7.CrossRefPubMed Cardillo G, Carbone L, Carleo F, Galluccio G, Di Martino M, Giunti R, et al. The rationale for treatment of postresectional bronchopleural fistula: analysis of 52 patients. Ann Thorac Surg. 2015;100:251–7.CrossRefPubMed
23.
go back to reference Brunelli A, Dinesh P, Woodcock-Shaw J, Littlechild D, Pompili C. Ninety-day mortality after video-assisted thoracoscopic lobectomy: incidence and risk factors. Ann Thorac Surg. 2017;104:1020–6.CrossRefPubMed Brunelli A, Dinesh P, Woodcock-Shaw J, Littlechild D, Pompili C. Ninety-day mortality after video-assisted thoracoscopic lobectomy: incidence and risk factors. Ann Thorac Surg. 2017;104:1020–6.CrossRefPubMed
24.
go back to reference Gacouin A, Locufier M, Uhel F, Letheulle J, Bouju P, Fillatre P, et al. Liver cirrhosis is independently associated with 90-day mortality in ARDS patients. Shock. 2016;45:16–21.CrossRefPubMed Gacouin A, Locufier M, Uhel F, Letheulle J, Bouju P, Fillatre P, et al. Liver cirrhosis is independently associated with 90-day mortality in ARDS patients. Shock. 2016;45:16–21.CrossRefPubMed
25.
go back to reference Yepes-Temiño MJ, Monedero P, Pérez-Valdivieso JR. Grupo Español de Anestesia Toracica. Risk prediction model for respiratory complications after lung resection: an observational multicentre study. Eur J Anaesthesiol. 2016;33:326–33.CrossRefPubMed Yepes-Temiño MJ, Monedero P, Pérez-Valdivieso JR. Grupo Español de Anestesia Toracica. Risk prediction model for respiratory complications after lung resection: an observational multicentre study. Eur J Anaesthesiol. 2016;33:326–33.CrossRefPubMed
26.
go back to reference Iwata T, Yoshida S, Fujiwara T, Wada H, Nakajima T, Suzuki H, et al. Effect of perioperative pirfenidone treatment in lung cancer patients with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2016;102:1905–10.CrossRefPubMed Iwata T, Yoshida S, Fujiwara T, Wada H, Nakajima T, Suzuki H, et al. Effect of perioperative pirfenidone treatment in lung cancer patients with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2016;102:1905–10.CrossRefPubMed
27.
go back to reference Takegahara K, Usuda J, Inoue T, Ibi T, Sato A. Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease. Gen Thorac Cardiovasc Surg. 2017;65:388–91.CrossRefPubMedPubMedCentral Takegahara K, Usuda J, Inoue T, Ibi T, Sato A. Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease. Gen Thorac Cardiovasc Surg. 2017;65:388–91.CrossRefPubMedPubMedCentral
28.
go back to reference Scott WJ, Allen MS, Darling G, Meyers B, Decker PA, Putnam JB, et al. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the american college of surgeons oncology group z0030 randomized clinical trial. J Thorac Cardiovasc Surg. 2010;139:976–81.CrossRefPubMed Scott WJ, Allen MS, Darling G, Meyers B, Decker PA, Putnam JB, et al. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the american college of surgeons oncology group z0030 randomized clinical trial. J Thorac Cardiovasc Surg. 2010;139:976–81.CrossRefPubMed
29.
go back to reference Kneuertz PJ, D’Souza DM, Moffatt-Bruce SD, Merritt RE. Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function. J Cardiothorac Surg. 2018;13:56.CrossRefPubMedPubMedCentral Kneuertz PJ, D’Souza DM, Moffatt-Bruce SD, Merritt RE. Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function. J Cardiothorac Surg. 2018;13:56.CrossRefPubMedPubMedCentral
30.
go back to reference Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 2006;81:1028–32.CrossRefPubMed Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 2006;81:1028–32.CrossRefPubMed
31.
go back to reference Tsubochi H, Shibano T, Endo S. Recommendations for perioperative management of lung cancer patients with comorbidities. Gen Thorac Cardiovasc Surg. 2018;66:71–80.CrossRefPubMed Tsubochi H, Shibano T, Endo S. Recommendations for perioperative management of lung cancer patients with comorbidities. Gen Thorac Cardiovasc Surg. 2018;66:71–80.CrossRefPubMed
32.
go back to reference Jichen QV, Chen G, Jiang G, Ding J, Gao W, Chen C. Risk factor comparison and clinical analysis of early and late bronchopleural fistula after non-small cell lung cancer surgery. Ann Thorac Surg. 2009;88:1589–93.CrossRefPubMed Jichen QV, Chen G, Jiang G, Ding J, Gao W, Chen C. Risk factor comparison and clinical analysis of early and late bronchopleural fistula after non-small cell lung cancer surgery. Ann Thorac Surg. 2009;88:1589–93.CrossRefPubMed
Metadata
Title
Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan
Authors
Shunsuke Endo
Norihiko Ikeda
Takashi Kondo
Jun Nakajima
Haruhiko Kondo
Yoshihisa Shimada
Masami Sato
Shinichi Toyooka
Yoshinori Okada
Yukio Sato
Ichiro Yoshino
Morihito Okada
Meinoshin Okumura
Masayuki Chida
Eriko Fukuchi
Hiroaki Miyata
Publication date
01-03-2019
Publisher
Springer Singapore
Published in
General Thoracic and Cardiovascular Surgery / Issue 3/2019
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-018-1022-y

Other articles of this Issue 3/2019

General Thoracic and Cardiovascular Surgery 3/2019 Go to the issue